MentionFox
Home › funding signals › Arcadia Biosciences, Inc.
Form D · on the record

Arcadia Biosciences — $4M Form D filing, June 2026

Arcadia Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-26.

Arcadia Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 26, 2026. The filing reports $4M sold. Its industry group is Other Technology. It names Thomas Schaefer (Executive Officer, Director), Kevin Comcowich (Director), Amy Yoder (Director) (SEC Form D, June 26, 2026).

Sell to companies like Arcadia Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

5 more Other Technology raises in Texas, June 2026 ↓

Is this your company?

Key facts

Run the free check on Arcadia Biosciences, Inc. →

Arcadia Biosciences, Inc.

New Form D on file · 2026-06-26 · the record

$4M
raise on the record
D
filing
5
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2026-06-26
Industry groupOther Technology
Entity typeCorporation
Incorporated inDELAWARE
BasedDALLAS, TEXAS
CIK1469443
Accession0001469443-26-000002

Pitching, partnering or investing alongside them? See who really runs and owns Arcadia Biosciences, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Arcadia Biosciences, Inc., from the filings we hold.

Raised through the same sales agent

H.C. Wainwright & Co, LLC received sales compensation on this raise and on 29 other raises we hold, nearest in date first:

More raises like this

Other Technology raises by companies based in Texas, filed in June 2026, largest first.

What do you want to do with Arcadia Biosciences, Inc.?

Get the full cited report on Arcadia Biosciences, Inc.

What the filing shows about Arcadia Biosciences, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Arcadia Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Arcadia Biosciences, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Arcadia Biosciences, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Arcadia Biosciences, Inc.'s address as 5956 Sherry Lane, Suite 2000, Dallas, TX 75225.

What the filing says

  • Offered: $11,417,964. Sold: $3,999,613. Left to sell: $7,418,351. (filing)
  • Investors: 5 had already invested. (filing)
  • Date of first sale: June 12, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Includes gross proceeds received from issuance of pre-funded warrants & preferred investment options. Offering also reflects the aggregate exercise price of pre-funded warrants, preferred investment options and placement agent investment options issued.” (filing)
  • On sales commissions and finders' fees: the filing adds “In addition to cash fee, the company paid certain expenses of $75,000 and issued placement agent preferred investment options to purchase up to 271,845 shares of common stock at exercise price $1.2875 per share.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Arcadia Biosciences, Inc. See pricing

Is Arcadia Biosciences, Inc. a real, registered company?

Arcadia Biosciences, Inc. is a registered filer with the SEC (CIK 1469443) and has filed since 2026-01-27. 2 filings are on record, the latest on 2026-06-26.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Arcadia Biosciences, Inc.?

Arcadia Biosciences, Inc.'s Form D of 2026-06-26 names Thomas Schaefer, Kevin Comcowich, Amy Yoder and 2 more as its officers, directors or promoters.

How much has Arcadia Biosciences, Inc. raised?

Its new offerings report $6.08M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2026-01-27 · $2.08MForm D · 2026-06-26 · $4M · this page 2026-01-27 2026-06-26

Each marker is one filing. The larger marker is the filing this page is about.

Other Technology · by week
This raise, $4M, filed week of Jun 22

Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $4M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Arcadia Biosciences, Inc.?

What the filing shows about Arcadia Biosciences, Inc.

  • 5 investors had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Arcadia Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Arcadia Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (arcadiabio.com).

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Arcadia Biosciences, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Arcadia Biosciences, Inc.: Raised $4M, Form D filed 2026-06-26
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/arcadia-biosciences-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Arcadia Biosciences raised $4M — SEC Form D filing, June 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/arcadia-biosciences-inc-form-d-26000001